As of Jun 22
| +0.25 / +0.22%|
The 23 analysts offering 12-month price forecasts for Zimmer Biomet Holdings Inc have a median target of 133.00, with a high estimate of 158.00 and a low estimate of 110.00. The median estimate represents a +19.01% increase from the last price of 111.76.
The current consensus among 25 polled investment analysts is to Buy stock in Zimmer Biomet Holdings Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.